Objective-Atherosclerosis is a chronic and progressive inflammatory disease of the arteries that is characterized by subendothelial accumulation of lipid-rich macrophages, called foam cells. We sought to identify the molecular details of cross-talk between liver X receptor ␣ (LXR␣) and hypoxia-inducible factor 1␣ (HIF-1␣) for the formation of triglyceride-rich foam cells under hypoxic conditions. Methods and Results-We first observed that expression of LXR␣ and its target lipogenic genes was time-dependently induced in human primary macrophages and RAW 264.7 cells under hypoxia. Similarly, TO901317, an activator of LXR␣, enhanced the expression level and the transcriptional activity of HIF-1␣. Second, we demonstrated that LXR␣ increased HIF-1␣ protein stability through a physical interaction between the ligand binding domain of LXR␣ and the oxygen-dependent degradation domain of HIF-1␣. Third, we found that the activation of HIF-1␣ or LXR␣ synergistically induced triglyceride accumulation in macrophages. Finally, we showed that LXR␣ and HIF-1␣ were codistributed in the macrophages of atherosclerotic lesions of patients.
A therosclerosis is a chronic and progressive inflammatory disease of the arteries that is characterized by subendothelial accumulation of lipid-rich macrophages, called foam cells. 1, 2 Although the mechanism has not been clearly established, hypoxic conditions in atherosclerotic lesions contribute to the formation of foam cells. 3, 4 Chronic intermittent hypoxia, a condition caused by obstructive sleep apnea, is often associated with atherosclerosis, hyperlipidemia, and a high cardiovascular risk. 5 Indeed, an experimental chronic intermittent hypoxia induces atherosclerosis in the presence of diet-induced dyslipidemia in animals. 6 The modulation of multiple genes involved in lipid metabolism is associated with hypoxia. Intermittent hypoxia increases mRNA and protein levels of stearoyl-coenzyme A desaturase 1 , an important enzyme in the biosynthesis of triglyceride and phospholipid. 5, 7 A sterol regulatory element binding protein (SREBP) analog in yeast is upregulated in response to low oxygen, and a similar effect is expected in mammalian cells. 8 RNA interference of hypoxia-inducible factor-1␣ (HIF-1␣), the major transcription regulator of cells exposed to hypoxic conditions, inhibits the formation of macrophage-derived foam cells, and decreases expression of lipogenic genes, such as the liver X receptor (LXR), adipocyte differentiation-related protein and peroxisome proliferator-activated receptors (PPARs). 9 In a murine model, hypoxia induced an increase in SREBP cleavage-activating protein levels, which was significantly attenuated by partial deficiency of HIF-1␣. 10 These observations indicate that HIF-1␣ plays an important role in lipid metabolism and in the formation of lipid-loaded macrophages under hypoxic conditions.
LXR␣ is a nuclear receptor that regulates genes controlling lipid metabolism. LXR␣ is activated by oxysterols as well as by intermediate products of the cholesterol biosynthetic pathway. 11, 12 In addition to its well-established role in lipid metabolism, LXR␣ regulates transcriptional programs involved in the inflammatory response. 13 Because LXR␣ is richly expressed in macrophages in atherosclerotic lesions found in humans, many studies have investigated the LXR␣ signaling pathway in atherosclerosis using mouse models or primary macrophages obtained from humans. 14 -16 It is encouraging that a protective role of LXR␣ in atherogenesis was evidenced in some of the cardiovascular disease models. Nevertheless, synthetic LXR ligands have been shown to induce lipogenesis and hypertriglyceridemia in mice, raising concerns about the development of these ligands as therapeutic agents against cardiovascular disease. 17, 18 These paradoxical outcomes from the LXR␣ activation pathway in athero-sclerosis disease models could be a major hurdle for designing strategies using LXR ligands to treat cardiovascular disease.
Increasing volumes of data strongly suggest that hypoxia signaling is interconnected with lipid metabolism in inflammatory macrophages, especially for LXR-mediated lipogenesis. Therefore, in this study, we explored the potential cross-talk between HIF-1-mediated hypoxia signaling and LXR-induced triglyceride synthesis in macrophages. Here, we provide evidence that hypoxia induces the activation of LXR␣ through stabilization of HIF-1␣, which may provide an important molecular mechanism for the formation of triglyceride-rich foam cells during the development of atherosclerosis.
Materials and Methods
Peripheral blood mononuclear cells were obtained from healthy donors by ficoll-hypaque density gradient centrifugation. The murine macrophage cell line, RAW 264.7, and the human monocytic cell line, THP-1, were obtained from American-type culture collection. Hypoxic conditions were generated by exposing cells to 0.1% O 2 or treating cells with desferrioxamine (DFO) or cobalt chloride (CoCl 2 ), known hypoxia mimicking agents. 19 The plasmid encoding AF2/helix2 mutant was kindly provided by Dr Lee Y.C at Chonnam National University (Gwangju, Korea). Atherosclerotic plaques were obtained during surgery at Kyungpook National University School of Medicine (Daegu, Korea). Details of Western blot analysis, immunoprecipitation, subcellular fractionation, plasmid transient transfection, mammalian 2-hybrid assay, RNA interference-mediated silencing of LXR␣ and HIF-1␣, RT-PCR and real-time PCR, lipid staining and analysis, ChIP assay, and statistical analyses are available online in the supplemental materials at http://atvb.ahajournals.org.
Results

Expression of LXR and Its Downstream Target Genes Increases Under Hypoxia
The LXR␣ protein is expressed in macrophage-lineage foam cells at various stages of atherosclerotic lesions in which hypoxic stress is a prominent feature. 11, 15 Therefore, we hypothesized that cross-talk between HIF-1␣ and LXR␣ may occur in macrophages under hypoxia, which may contribute to atherosclerotic plaque formation. Therefore, we first examined whether expression of LXR␣ and its downstream target genes was influenced under hypoxic conditions. Primary human macrophages obtained from healthy donors were cultured under hypoxia. Protein and mRNA levels of LXR␣ and its downstream target genes, SREBP-1c and fatty acid synthase, increased under hypoxia, which was similar to the induction of HIF-1␣ and VEGF under the same conditions. Although protein level of LXR␤ was not changed much, mRNA level of LXR␤ was slightly increased in the human macrophages ( Figure 1A , Supplemental Figure I ). Although the presence of LXR␣ has been controversial in murine RAW 264.7 cells, we observed clear induction of both LXR␣ and LXR␤ in the cells on hypoxic treatment ( Figure 1A and 1B). 20, 21 Consistent with the increase in mRNA level of LXR␣, a reporter encoding the 5Ј upstream promoter of the human LXR␣ gene was activated in the presence of DFO, a hypoxia-mimicking reagent. 20 Six putative hypoxia response elements are present in the LXR␣ gene promoter, to which HIF-1␣ was efficiently and preferentially recruited on treat- Total RNA was prepared and analyzed for expression of the indicated transcripts by qRT-PCR using specific primers. C, HeLa cells were transiently transfected with the human LXR␣promoter-Luc and were treated with 100 mol/L desferrioxamine (DFO) and/or 1 mol/L T17 for 18 hours (left). Schematic representation of the human LXR␣ promoter investigated in this study. Sticks indicate the presence of putative hypoxia response elements (right, upper). THP-1 cells were treated with 100 mol/L DFO for 12 hours. DNA fragments that immunoprecipitated were amplified by PCR using primers that amplify the DNA fragment a, b, and c as indicated (right, lower). D, RAW 264.7 cells were transfected with si-RNAs as indicated and treated with 0.1% O 2 for 12 hours. Whole cell lysates were analyzed by Western blotting. *PϽ0.05, and **PϽ0.01 vs vehicle treatment (nϭ3). # PϽ0.01, and ## PϽ0.005 vs desferrioxamine (DFO) or T17 treatment (nϭ3). One representative of at least 3 independent experiments with similar results is shown. SREBP indicates sterol regulatory element binding protein; FAS, fatty acid synthase; HIF-1␣, hypoxia inducible factor-1␣. ment with DFO, when examined with THP-1 cells ( Figure  1C ). Knockdown of HIF-1␣ using si-RNA completely abolished the induction of LXR␣, SREBP-1, and fatty acid synthase, indicating that the induction of LXR was HIF-1␣dependent. Interestingly, knockdown of LXR␣ also blocked the induction of HIF-1␣, further suggesting the existence of cross-talk between hypoxia and LXR␣ signaling ( Figure 1D ). Together, these results demonstrated that HIF-1␣ is induced under hypoxia and activates transcription of LXR␣ by binding to the hypoxia response elements in the LXR␣ gene promoter.
TO901317 Induces Protein Stability and Transcriptional Activation of HIF-1␣
Next, we tested whether LXR␣ was involved in hypoxia signaling in primary human macrophages and murine RAW 264.7 cells. Treatment of both cell types with TO901317 increased the level of HIF-1␣ protein and its target VEGF, along with the induction of LXR␣, in a time-and dosedependent manner (Figure 2A , Supplemental Figure II ). In the presence of TO901317, VEGF, LXR␣, and LXR␤, mRNA levels in RAW 264.7 cells were greatly increased; however, HIF-1␣ mRNA levels were unchanged, indicating that the induction of HIF-1␣ was achieved at the posttranscriptional level ( Figure 2B ). A more specific ligand of LXR␣, GW3965, also induced the protein level of HIF-1␣ and VEGF (Supplemental Figure III) . 22 Overexpression of LXR␣ in RAW 264.7 cells increased the level of HIF-1␣ protein to the same extent as treatment with DFO ( Figure 2C ). Knockdown of LXR␣ or LXR␣/␤ using si-RNA completely abolished the induction of HIF-1␣, indicating that the induction of HIF-1␣ was LXR-dependent ( Figure 2D ). The AF2/ helix12 mutant (LLSEAA)-lacking transactivation function did not increase HIF-1␣ protein level, suggesting that ligand binding of LXR␣ is required for the induction of HIF-1␣ protein (Supplemental Figure IVA ). 23 We also checked the involvement of RXR␣, a heterodimer partner of LXR␣. Overexpression of RXR␣ alone did not increase HIF-1␣ protein level, but together with LXR␣ significantly increased the HIF-1␣ protein level (Supplemental Figure IVB ).
Next, we tested whether LXR␣ enhanced the stability of the HIF-1␣ protein. For this purpose, we used cycloheximide, an inhibitor of de novo protein synthesis. Treatment with TO901317 or overexpression of LXR␣ blocked degradation of HIF-1␣ in RAW 264.7 cells ( Figure 3A) . The proteasomal inhibitor, MG132, strongly increased the amount of ubiquitinated HIF-1␣. Overexpression of LXR␣ as well as treatment with TO901317 decreased the ubiquitinated HIF-1␣ to the same extent as hypoxia in RAW 264.7 cells ( Figure 3B ). We further investigated whether LXR␣ reduced the binding of HIF-1␣ to prolyl hydroxylases (PHDs), because HIF-1␣ undergoes proteasomal degradation after prolyl hydroxylation. 19 The amount of HIF-1␣ bound to PHDs was largely decreased in the presence of LXR␣ or under hypoxia ( Figure  3C ). Together, these results indicate that a positive activation loop between the hypoxia-mediated LXR␣ induction and the LXR␣-induced activation of HIF-1␣ was generated under hypoxic conditions in macrophages.
LXR␣ Interacts With HIF-1␣ in the Nucleus and Increases the Transactivation Function of HIF-1␣
To further characterize the cross-talk between LXR␣ and HIF-1␣, we examined whether these proteins were physically associated. First, LXR␣ and HIF-1␣ were distributed in the nucleus under hypoxia or in the presence of TO901317 (Supplemental Figure V) . A coimmunoprecipitation assay demonstrated that LXR␣ and HIF-1␣ physically interacted ( Figure 4A ). Further, a mammalian 2-hybrid assay using the Gal4-driven luciferase reporter, the Gal4 DBD-fused LXR␣, and the VP16-fused HIF-1␣, confirmed that LXR␣ and HIF-1␣ physically interacted ( Figure 4B ). We delineated the interacting domains using the truncated FLAG-tagged LXR␣ and the GST-fused HIF-1␣. 19 The coimmunoprecipitation experiments revealed that the oxygen-dependent degradation do- main of HIF-1␣ bound to LXR␣, whereas the ligand-binding domain (LBD) of LXR␣ served as the binding site for HIF-1␣ ( Figure 4C ). The importance of this binding was indicated by the LBD of LXR␣ being sufficient to induce the increases in protein levels as well as transcriptional activity of HIF-1␣ ( Figure 4D ). Next, we examined whether LXR␣ enhanced the transactivation function of HIF-1␣, using a Gal4-driven luciferase reporter system. The full-length and LBD, but not the N-terminus or DNA-binding domains of LXR␣, strongly enhanced Gal4-HIF-1␣-induced reporter Expression of the indicated proteins was analyzed by western blot analysis (WB) (upper). The density of each protein band was determined with an image analysis system and normalized to that of the corresponding ␣-tubulin (lower). B, RAW 264.7 cells were transfected with EV or Myc-LXR␣ together with HA-ubiquitin (Ub). Cells transfected with EV were treated with 0.1% O 2 for 12 hours or 1 mol/L TO901317 (T17) for 24 hours. Cells were then treated with 10 mol/L MG132 for 3 hours before being harvested. Whole cell lysates were immunoprecipitated (IP) and analyzed by WB. Protein level of hypoxia inducible factor-1␣ (HIF-1␣) in whole cell lysates was determined by WB as input. C, NIH3T3 cells were transfected with expression vectors encoding GFP-PHD1, GFP-PHD2, and GFP-PHD3 with or without pCMV-Myc-LXR␣ as indicated. Transfected cells were incubated under hypoxia or normoxia for 12 hours. Cells were treated with or without 10 mol/L MG132 for 3 hours before being harvested. Whole cell lysates were immunoprecipitated and analyzed by Western blotting. One representative of at least 3 independent experiments with similar results is shown.
activity. However, the activity of Gal4-LXR␣ was not altered by HIF-1␣ ( Figure 4E ). Consistent with this result, a ChIP assay showed that LXR␣, HIF-1␣, and the coactivator, CREB binding protein, were able to bind to hypoxia response elements on the promoter of HIF-1␣ target genes such as Glut-1 and erythropoietin ( Figure 4F ). 24 This result indicates that the physical interaction of HIF-1␣ and LXR␣ may enhance the transactivation function of HIF-1␣ by recruiting CREB binding protein onto the promoter of HIF-1␣ target genes.
Positive Cross-Talk Between HIF-1␣ and LXR␣ in the Lipogenesis of Macrophages
Next, we examined whether lipogenesis increased in macrophages as a consequence of the positive cross-talk between LXR␣ and HIF-1␣. Hypoxia and TO901317 treatment led to synergistic lipid accumulation in RAW 264.7 cells ( Figure  5A ). Importantly, knockdown of LXR␣ or HIF-1␣ using si-RNA largely blocked the lipid accumulation induced by hypoxia or TO901317 treatment in RAW 264.7 cells ( Figure  5B ). Treatment with DFO and/or TO901317 significantly increased the amount of triglyceride and total cholesterol in these cells ( Figure 5C) . Surprisingly, the level of ApoE protein increased in both cell pellets and media (Supplemental Figure VI) . The expression of representative lipogenic genes, such as adipocyte differentiation-related protein and stearoyl-coenzyme A desaturase 1, was also increased by treatment with DFO or TO901317 in RAW 264.7 cells. The induction of these genes was efficiently inhibited by transfection of si-RNAs or by treatment with the LXR antagonist, 22(S)-HC ( Figure 5D ).
Proinflammatory cytokines such as interleukin-1␤ (IL-1␤) and tumor necrosis factor ␣ (TNF␣) induce the expression of HIF-1␣ in inflammatory lesions. Therefore, we tested whether the positive cross-talk between LXR␣ and HIF-1␣ contributed to the cytokine-induced HIF-1␣ expression. As reported previously, IL-1␤ or TNF␣ increased the expression of HIF-1␣ protein as well as important proinflammatory signaling molecules such as inducible nitric oxide synthase and cyclooxygenase-2. Interestingly, the expression of LXR␣, SREBP-1c, and fatty acid synthase increased in a similar manner ( Figure 6A and Supplemental Figure VII) . Transfection of si-LXR␣ effectively decreased the levels of HIF-1␣ and LXR␣ protein, suggesting that LXR␣ plays an important role in the cytokine-induced inflammatory responses mediated by HIF-1␣ ( Figure 6B ). Finally, immunohistochemical staining of LXR␣ and HIF-1␣ in the specimens obtained from patients with atherosclerosis showed that each protein was localized in the monocytes in the atheroma. Double immunofluorescence staining revealed that expression of LXR␣ and HIF-1␣ largely overlapped in the region where the macrophage surface protein, CD68, was expressed (Supplemental Figure VIII) . Taken together, these observations suggest that the positive cross-talk between HIF-1␣ and LXR␣, along with coordinated transcriptional induction and regulation of protein stability in the macrophages, is a key step in the formation of foam cells, which leads to the formation of atherosclerotic lesions ( Figure 6C ). (T17) . B, RAW 264.7 cells were transfected with si-RNAs and were treated with 0.1% O 2 for 24 hours and/or 1 mol/L T17 for 96 hours. At the end of treatment, lipid droplets were stained using Nile-red, and fluorescence was determined by flow cytometry. C, RAW 264.7 cells were incubated with 100 mol/L desferrioxamine (DFO) for 12 hours or 1 mol/L TO901317 for 48 hours. Cell pellets and culture media were analyzed for triglycerides and total cholesterol. D, RAW 264.7 cells were incubated with 100 mol/L DFO for 12 hours or 1 mol/L TO901317 (T17) for 24 hours (left). RAW 264.7 cells were transfected with the indicated si-RNAs. After 3 hours of transfection, the cells were treated with 22(S)hydroxycholesterol (HC) or vehicle for 24 hours (right). Total RNA was prepared and analyzed for expression of the indicated transcripts by qRT-PCR. *PϽ0.05, **PϽ0.01, and ***PϽ0.001 vs vehicle treatment (nϭ3). # PϽ0.01, and ## PϽ0.005 vs DFO or T17 treatment (nϭ3). One representative of at least 3 independent experiments with similar results is shown.
Discussion
Hypoxic regions in atherosclerotic lesions contain large numbers of foam cells, revealing that these cells experience hypoxia during the development of atherosclerosis. Therefore we hypothesized that hypoxia induces a cross-talk between HIF-1␣ and LXR␣, which results in enhanced lipogenesis in macrophages, leading to foam-cell formation. In this study we characterized the molecular details of the cross-talk between HIF-1␣ and LXR␣. First, the transcription of LXR␣ was increased in the macrophages under hypoxia, which is achieved via the several hypoxia response elements scattered in the promoter region of the LXR␣ gene. The reporter containing the 5Ј upstream promoter of LXR␣ was well-activated under hypoxia and the binding of HIF-1␣ to the promoter region was demonstrated by a ChIP assay ( Figure  1C ). This finding may explain why knockdown of HIF-1␣ inhibits the expression of LXR␣, which was observed previously. 9 Second, LXR␣ enhances the stability of the HIF-1␣ protein. This is achieved by the direct interaction of LXR␣ with HIF-1␣, which diminishes the association of HIF-1␣ with PHDs ( Figure 3C ). Further binding of LXR␣ with HIF-1␣ recruits more CREB binding protein, which activates the transactivation function of HIF-1␣ ( Figure 4F ). Therefore, we speculate that environmental and intracellular stimuli that trigger HIF-1␣ or LXR␣ turn on this positive feedback circuit, which augments the hypoxia and lipogenic signaling pathways.
The lipogenic function of LXR␣ in the liver is well established; however, the role of LXR in foam-cell formation is not yet clearly understood. 25 Macrophages isolated from human atherosclerotic plaques predominantly contain cholesterol esters with substantial amounts of triglyceride. 26 Because a large amount of oxidized derivatives of cholesterol, oxysterols, known endogenous activators of LXR, are present in macrophage-derived foam cells or human atherosclerotic plaques, [27] [28] [29] the transcriptional activity of LXR␣ can be activated to trigger downstream targets. Indeed, we have demonstrated that activation of LXR␣ increases the expression of SREBP-1c and fatty acid synthase, which leads to increased levels of triglyceride in RAW 264.7 cells (Figure 2 and 5). We also observed that both hypoxia and TO901317 treatment increased expression of the reverse cholesterol transporters such as ABCA1 and ABCG1, direct downstream targets of LXR␣. 30 Also the scavenger receptor CD36 was increased under the same conditions, which may suggest that the uptake of cholesterol overrides the efflux of cholesterol by ABC transporters when foam cells were formed under hypoxic condition (Supplemental Figure IX) . 31, 32 Taken together, the accumulation of potential LXR ligands and the resulting enhancement of hypoxic signaling in the atherosclerotic lesion may contribute to increases in the levels of cholesterol and triglyceride in the macrophages.
Hypoxic conditions generated at the atherosclerotic lesion may be of fundamental importance for the vascular inflammatory processes as well. Hypoxia induces the expression of a variety of proinflammatory cytokines, such as 15-lipoxygenase-2, eicosanoids, IL-1␤, and TNF␣. 33, 34 The cytokines may induce inflammatory responses involving the increased production of lipid droplets. 35 Conversely, activation of LXR␣ by its oxysterol ligands stimulates mRNA synthesis and protein expression of TNF␣. 36 Interestingly, TNF␣ and VEGF are direct targets of LXR␣, indicating that LXR␣ and HIF-1␣ signaling may be coupled with inflammatory responses in atherosclerotic lesions. 36, 37 Therefore, we assessed whether the positive feedback circuit of HIF-1␣ and LXR␣ activation described in foam-cell formation operated for inflammatory responses. We showed that the increased expression of HIF-1␣ resulting from treatment with IL-1␤ and TNF␣ induced the expression of lipogenic genes including LXRs and their target genes ( Figure 6A) . Surprisingly, knockdown of LXR␣ effectively inhibited the HIF-1␣ protein levels ( Figure 6B ). These observations support the notion that the hypoxia-induced inflammatory process is accompanied by the accumulation of lipids and that the positive feedback circuit of HIF-1␣ and LXR␣ in macrophage cells may be a Figure 6 . Increases in expression level of liver X receptor ␣ (LXR␣) and hypoxia inducible factor-1␣ (HIF-1␣) after treatment of inflammatory cytokines. A, RAW 264.7 cells were treated with 10 ng/mL IL-1␤ or TNF␣ for the indicated period. B, RAW 264.7 cells were transfected with si-control or si-LXR␣ and treated with 10 ng/mL IL-1␤ or TNF␣ for 24 hours. The whole cell lysates were analyzed for expression of the indicated proteins by western blot analysis. One representative of at least 3 independent experiments with similar results is shown. C, Schematic model for cross-talk of HIF-1␣ and LXR␣ in the foam cell formation of human atherosclerotic lesions. SREBP indicates sterol regulatory element binding protein; FAS, fatty acid synthase. key step in coordinating the cellular events that result in atherosclerotic lesions by linking inflammation and lipogenesis.
In general, cholesterol rather than triglycerides is the most atherogenic lipids accumulated in foam cells. However, in atherosclerotic lesions, the content of triglyceride is 3-fold in musculo-elastic layer and 13-fold in elastic hyperplastic layer of intima to compare with normal aorta, indicating that the increases in triglyceride level also contribute to the pathogenesis of atherosclerosis. 38 Particularly, atherosclerogenesis in hyper glyceridemic individuals is associated with the increased concentrations of very low-density lipoproteins (VLDL) and VLDL-associated remnant particles in atherosclerotic lesions. 39 A number of studies have shown that VLDL particles contribute directly to the accumulation of both extracellular and intracellular lipids in the lesions. 40 Therefore, LXR␣ may play a protective role by increasing cholesterol esterification and efflux, especially in the initial stage of atherosclerosis, however, it may contribute to excessive accumulation of intracellular and extracellular triglyceride in the late stage of the disease. In addition, hypoxia upregulates VLDL receptors on macrophages, and high levels of VLDL receptors are expressed by plaque macrophages in vivo, suggesting that hypoxic conditions may further enhance the VLDL-associated accumulation of triglyceride in the progressed atherosclerotic plaques. 41 However, a recent study showed that overexpression of SREBP-1c and concomitant changes in macrophage lipogenesis do not alter atherosclerotic lesion formation in the bone marrow-specific SREBP-1 deficient mice. 42 Thus the clinical relevance of these experimental findings including ours should be carefully assessed.
Trials of LXR␣ ligands as therapeutics for atherosclerosis have been controversial. Because genes involved in the efflux of cholesterol are direct downstream targets of LXR␣, as described above, the level of cholesterol in the macrophages is expected to decrease with LXR␣ activation. In experimental animals, the constitutive activation of LXR␣ in the intestinal epithelium reduced atherosclerosis by decreasing intestinal cholesterol absorption, improving lipoprotein composition, and stimulating reverse-cholesterol transport, which provided the rationale for LXR being an appealing drug target for atherosclerosis. 14, [43] [44] [45] However, administration of synthetic LXR ligands triggers the induction of the lipogenic pathway and elevates plasma triglyceride levels via SREBP-1. In LdlrϪ/Ϫ mice, TO901317 increases mRNA for enzymes involved in fatty acid biosynthesis and produces massive hypertriglyceridemia. 16, 17, 46 To complicate matters further, a proinflammatory role of LXRs was seen in primary human macrophages, which was in contrast to previous observations of LXRs as negative regulators of inflammatory gene expression. 47, 48 LXR activation augmented the production of inflammatory cytokines IL-12, TNF-␣, IL-6, and IL-8 in human monocyte-derived immune cells. 49 Here, our results reveal a new aspect of LXR action, which augments hypoxiainduced cellular signaling in the macrophages. Thus, the positive feedback circuit connecting activation of HIF-1␣ and LXR␣ may represent a new potential target for the prevention of foam-cell formation and inflammation in arterial walls and further progression to atherosclerosis.
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